본문으로 건너뛰기
← 뒤로

Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy.

Drug design, development and therapy 2026 Vol.20() p. 558923

Ma H, Zhang X, Li R, Qu B, Liu Y, Cui Y, Zhang T, Zhao J

📝 환자 설명용 한 줄

Hypericin, a polycyclic quinone derived from *Hypericum perforatum* (St.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Ma H, Zhang X, et al. (2026). Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy.. Drug design, development and therapy, 20, 558923. https://doi.org/10.2147/DDDT.S558923
MLA Ma H, et al.. "Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy.." Drug design, development and therapy, vol. 20, 2026, pp. 558923.
PMID 41836521

Abstract

Hypericin, a polycyclic quinone derived from *Hypericum perforatum* (St. John's Wort), has gained attention for its broad pharmacological activities, including anti-inflammatory, antimicrobial, and antitumor effects. It modulates key signaling pathways like NF-κB and MAPK, reducing chronic inflammation and making it effective in treating autoimmune and infectious skin conditions. As a photosensitizer, hypericin also induces apoptosis in abnormal cells through photodynamic therapy (PDT), showing promising results in treating cutaneous T-cell lymphoma (CTCL), psoriasis, and fungal infections. While its solubility and bioavailability remain challenges, hypericin's favorable safety profile and therapeutic potential position it as a valuable option for managing refractory dermatological conditions.

MeSH Terms

Humans; Perylene; Photochemotherapy; Anthracenes; Photosensitizing Agents; Animals; Immunologic Factors; Skin Diseases; Immunomodulating Agents

같은 제1저자의 인용 많은 논문 (5)